| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
290,515 |
274,929 |
$34.38M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
95,086 |
91,023 |
$15.91M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
13,972 |
13,842 |
$3.06M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16,849 |
16,830 |
$2.62M |
| 76641 |
|
11,937 |
11,806 |
$2.57M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13,526 |
13,521 |
$2.48M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,299 |
9,280 |
$2.05M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,630 |
13,624 |
$1.90M |
| 87631 |
|
10,905 |
10,735 |
$1.88M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12,176 |
12,163 |
$1.72M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15,922 |
15,115 |
$1.46M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
74,488 |
73,651 |
$1.36M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
8,048 |
7,099 |
$1.34M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,396 |
10,069 |
$1.31M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23,097 |
22,801 |
$1.31M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,806 |
7,800 |
$1.17M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,611 |
2,554 |
$1.04M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
6,381 |
6,377 |
$972K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12,951 |
12,948 |
$961K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,006 |
5,899 |
$944K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
27,286 |
26,822 |
$883K |
| 92060 |
|
11,146 |
11,050 |
$869K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
6,529 |
4,903 |
$831K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
18,556 |
18,321 |
$764K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
18,545 |
18,311 |
$764K |
| 31231 |
|
2,389 |
2,306 |
$667K |
| 76830 |
Ultrasound, transvaginal |
3,614 |
3,568 |
$628K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,249 |
4,471 |
$589K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,354 |
3,295 |
$530K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,198 |
6,939 |
$508K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
11,601 |
11,542 |
$482K |
| 99215 |
Prolong outpt/office vis |
2,027 |
1,864 |
$478K |
| A4550 |
Surgical trays |
1,942 |
1,462 |
$464K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,549 |
3,471 |
$450K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
2,371 |
2,371 |
$446K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
10,047 |
3,957 |
$415K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
4,468 |
4,362 |
$387K |
| 71046 |
Radiologic examination, chest; 2 views |
8,315 |
8,298 |
$375K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,120 |
3,098 |
$361K |
| 76536 |
|
2,455 |
2,426 |
$360K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,414 |
2,226 |
$354K |
| 81513 |
|
4,265 |
4,188 |
$349K |
| 88174 |
|
11,928 |
11,867 |
$349K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,234 |
1,181 |
$348K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
8,503 |
8,209 |
$344K |
| 76813 |
|
1,985 |
1,985 |
$343K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,739 |
2,731 |
$334K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
2,747 |
2,721 |
$334K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,320 |
1,320 |
$330K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,120 |
1,116 |
$270K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,930 |
8,541 |
$267K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,245 |
2,244 |
$241K |
| 76801 |
|
1,379 |
1,368 |
$234K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,684 |
23,497 |
$234K |
| 92250 |
|
6,198 |
5,575 |
$227K |
| 74183 |
|
547 |
547 |
$224K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
867 |
866 |
$204K |
| 77065 |
Tomosynthesis, mammo |
1,143 |
1,110 |
$204K |
| 80053 |
Comprehensive metabolic panel |
15,407 |
15,107 |
$204K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
503 |
503 |
$202K |
| 72197 |
|
401 |
401 |
$179K |
| 99205 |
Prolong outpt/office vis |
603 |
603 |
$179K |
| 99233 |
Prolong inpt eval add15 m |
1,196 |
501 |
$178K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,154 |
1,152 |
$178K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
887 |
885 |
$175K |
| 17110 |
|
1,101 |
945 |
$172K |
| 87428 |
|
3,874 |
3,810 |
$171K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
618 |
614 |
$168K |
| 92557 |
|
3,478 |
3,433 |
$167K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
960 |
959 |
$164K |
| 73630 |
|
3,377 |
2,790 |
$158K |
| 80061 |
Lipid panel |
10,548 |
10,526 |
$155K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,403 |
7,348 |
$153K |
| 92567 |
|
6,782 |
6,685 |
$152K |
| 87481 |
|
4,280 |
4,125 |
$151K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
563 |
563 |
$149K |
| 92551 |
|
20,625 |
20,618 |
$146K |
| 77066 |
Tomosynthesis, mammo |
650 |
643 |
$142K |
| 92015 |
Determination of refractive state |
10,568 |
10,555 |
$139K |
| 95117 |
|
7,677 |
3,967 |
$131K |
| 92134 |
|
2,413 |
2,190 |
$122K |
| 73562 |
|
2,070 |
1,718 |
$113K |
| 75574 |
|
342 |
339 |
$106K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
812 |
792 |
$105K |
| 76770 |
|
709 |
708 |
$103K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,515 |
3,510 |
$102K |
| 90461 |
|
5,627 |
5,601 |
$102K |
| 59426 |
|
1,063 |
649 |
$100K |
| 19083 |
|
130 |
126 |
$99K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,224 |
6,068 |
$95K |
| 00731 |
|
398 |
392 |
$94K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
72 |
72 |
$93K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,106 |
9,708 |
$90K |
| 93000 |
|
4,344 |
4,294 |
$89K |
| 96127 |
|
18,221 |
18,187 |
$89K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,424 |
12,296 |
$88K |
| 71250 |
|
566 |
566 |
$87K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,602 |
2,589 |
$80K |
| 84439 |
|
7,421 |
7,357 |
$78K |
| 92588 |
|
1,892 |
1,889 |
$75K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
592 |
590 |
$74K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
138 |
138 |
$72K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
132 |
131 |
$67K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,200 |
472 |
$67K |
| 80050 |
General health panel |
1,897 |
1,893 |
$66K |
| 76642 |
|
585 |
543 |
$66K |
| 73610 |
|
1,257 |
1,138 |
$63K |
| 72100 |
|
1,176 |
1,176 |
$62K |
| 77080 |
|
1,250 |
1,249 |
$61K |
| 92082 |
|
1,147 |
1,147 |
$60K |
| 36415 |
Collection of venous blood by venipuncture |
71,037 |
67,435 |
$60K |
| 92552 |
|
1,130 |
1,129 |
$56K |
| 73030 |
|
1,280 |
1,125 |
$56K |
| 41010 |
|
159 |
159 |
$51K |
| 82728 |
|
2,789 |
2,777 |
$47K |
| 73130 |
|
882 |
728 |
$46K |
| 73221 |
|
159 |
157 |
$42K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,200 |
1,177 |
$42K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
2,320 |
939 |
$41K |
| 70486 |
|
234 |
234 |
$41K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
102 |
102 |
$40K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
537 |
171 |
$40K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
298 |
255 |
$39K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,349 |
1,348 |
$39K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,114 |
4,102 |
$37K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
305 |
262 |
$36K |
| 92587 |
|
2,107 |
2,100 |
$35K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
148 |
148 |
$35K |
| 00811 |
|
168 |
160 |
$35K |
| 77072 |
|
792 |
792 |
$29K |
| 99385 |
|
166 |
166 |
$29K |
| 72141 |
|
114 |
114 |
$27K |
| 77062 |
|
341 |
339 |
$26K |
| 88342 |
|
130 |
128 |
$25K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
214 |
92 |
$25K |
| 82607 |
|
1,681 |
1,680 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,631 |
808 |
$24K |
| 90686 |
|
16,211 |
16,187 |
$24K |
| 81003 |
|
12,472 |
11,685 |
$24K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
199 |
199 |
$24K |
| 31575 |
|
121 |
121 |
$23K |
| 94010 |
|
739 |
671 |
$23K |
| 88142 |
|
960 |
956 |
$23K |
| 99459 |
|
732 |
718 |
$23K |
| 88141 |
|
661 |
661 |
$22K |
| 83550 |
|
1,992 |
1,980 |
$21K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,751 |
1,559 |
$21K |
| 99051 |
|
2,491 |
2,479 |
$21K |
| 00142 |
|
173 |
169 |
$21K |
| 73620 |
|
487 |
387 |
$20K |
| 86769 |
|
374 |
374 |
$20K |
| 81002 |
|
4,708 |
3,705 |
$20K |
| 74178 |
|
42 |
42 |
$20K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
54 |
53 |
$20K |
| 81025 |
|
2,330 |
2,260 |
$19K |
| 72040 |
|
358 |
358 |
$18K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
57 |
57 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
184 |
101 |
$17K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,772 |
1,768 |
$17K |
| 20610 |
|
192 |
187 |
$17K |
| 69210 |
|
356 |
341 |
$17K |
| 99173 |
|
20,998 |
20,934 |
$17K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
37 |
37 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,526 |
1,471 |
$14K |
| 0001A |
|
259 |
258 |
$14K |
| 0002A |
|
257 |
256 |
$14K |
| 00812 |
|
67 |
67 |
$14K |
| 92568 |
|
808 |
808 |
$13K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
66 |
66 |
$13K |
| 73110 |
|
253 |
216 |
$13K |
| 72110 |
|
203 |
203 |
$13K |
| 86803 |
|
795 |
792 |
$13K |
| S9083 |
Global fee urgent care centers |
39 |
39 |
$12K |
| 90674 |
|
4,506 |
4,491 |
$12K |
| 83540 |
|
1,476 |
1,465 |
$12K |
| 93970 |
|
50 |
50 |
$11K |
| 99188 |
|
786 |
786 |
$11K |
| 94664 |
|
541 |
513 |
$11K |
| 90834 |
Psychotherapy, 45 minutes with patient |
75 |
36 |
$10K |
| 86140 |
|
1,470 |
1,461 |
$9K |
| 97035 |
|
535 |
211 |
$9K |
| 95886 |
|
39 |
37 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
411 |
354 |
$9K |
| 73502 |
|
148 |
147 |
$9K |
| 92201 |
|
282 |
255 |
$9K |
| 77061 |
|
157 |
154 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
190 |
186 |
$8K |
| 88312 |
|
41 |
41 |
$8K |
| 99177 |
|
3,239 |
3,238 |
$8K |
| 92202 |
|
454 |
453 |
$8K |
| 72050 |
|
109 |
109 |
$8K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
143 |
63 |
$8K |
| 88304 |
|
109 |
109 |
$8K |
| 99223 |
Prolong inpt eval add15 m |
43 |
43 |
$8K |
| 87486 |
|
164 |
162 |
$7K |
| 87581 |
|
164 |
162 |
$7K |
| 87340 |
|
608 |
606 |
$7K |
| 0012A |
|
154 |
154 |
$7K |
| 0011A |
|
154 |
154 |
$7K |
| 94375 |
|
141 |
136 |
$7K |
| 77049 |
|
13 |
13 |
$7K |
| G0268 |
Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing |
264 |
257 |
$7K |
| 51798 |
|
515 |
502 |
$7K |
| 99417 |
Prolong home eval add 15m |
69 |
69 |
$7K |
| 93015 |
|
70 |
70 |
$7K |
| 86618 |
|
333 |
332 |
$7K |
| 94729 |
|
79 |
79 |
$7K |
| 99401 |
|
288 |
287 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
27 |
27 |
$6K |
| 92083 |
|
69 |
68 |
$6K |
| 0071A |
|
101 |
101 |
$6K |
| 92550 |
|
409 |
384 |
$6K |
| 0064A |
|
105 |
105 |
$5K |
| 58340 |
|
13 |
13 |
$5K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
34 |
24 |
$5K |
| 97162 |
|
51 |
48 |
$5K |
| 99386 |
|
25 |
25 |
$5K |
| 85652 |
|
1,488 |
1,481 |
$5K |
| 90661 |
|
1,877 |
1,876 |
$5K |
| 73564 |
|
79 |
70 |
$5K |
| 93971 |
|
28 |
28 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,350 |
1,305 |
$4K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
654 |
445 |
$4K |
| 0072A |
|
78 |
78 |
$4K |
| 90832 |
Psychotherapy, 30 minutes with patient |
41 |
24 |
$4K |
| 94060 |
|
68 |
68 |
$4K |
| 94727 |
|
68 |
68 |
$4K |
| 00813 |
|
17 |
17 |
$4K |
| 92285 |
|
309 |
309 |
$4K |
| 81001 |
|
1,038 |
1,010 |
$4K |
| 82550 |
|
477 |
476 |
$4K |
| 72070 |
|
88 |
88 |
$4K |
| 92504 |
|
146 |
129 |
$4K |
| 88112 |
|
39 |
39 |
$4K |
| 87081 |
|
701 |
689 |
$4K |
| 11102 |
|
25 |
25 |
$4K |
| 87807 |
|
440 |
422 |
$3K |
| 01936 |
|
14 |
13 |
$3K |
| 97799 |
|
74 |
38 |
$3K |
| 86708 |
|
217 |
217 |
$3K |
| 0004A |
|
59 |
59 |
$3K |
| 73560 |
|
62 |
58 |
$3K |
| 82746 |
|
350 |
350 |
$3K |
| 0124A |
|
50 |
50 |
$3K |
| 01938 |
|
23 |
15 |
$3K |
| 90677 |
|
485 |
484 |
$3K |
| 97802 |
|
186 |
185 |
$2K |
| 86704 |
|
222 |
222 |
$2K |
| 74018 |
|
55 |
55 |
$2K |
| 86706 |
|
243 |
243 |
$2K |
| 3074F |
|
7,876 |
7,465 |
$2K |
| 84702 |
|
135 |
114 |
$2K |
| 99429 |
|
238 |
237 |
$2K |
| 88143 |
|
86 |
86 |
$2K |
| 87071 |
|
678 |
655 |
$2K |
| 83655 |
|
145 |
145 |
$2K |
| 92133 |
|
42 |
40 |
$2K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
87 |
64 |
$2K |
| 92579 |
|
40 |
40 |
$2K |
| 90715 |
|
276 |
276 |
$2K |
| 82977 |
|
217 |
216 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
186 |
184 |
$2K |
| 83735 |
|
235 |
234 |
$2K |
| 0240U |
|
20 |
19 |
$2K |
| 99201 |
|
26 |
26 |
$2K |
| 85018 |
|
860 |
855 |
$2K |
| 76514 |
|
134 |
134 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
437 |
399 |
$2K |
| 90636 |
|
12 |
12 |
$2K |
| 99442 |
|
14 |
13 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
154 |
146 |
$1K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
21 |
13 |
$1K |
| 85027 |
|
241 |
238 |
$1K |
| 85045 |
|
219 |
213 |
$1K |
| 3079F |
|
3,464 |
3,337 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
72 |
68 |
$1K |
| 3078F |
|
5,283 |
5,021 |
$1K |
| 86141 |
|
66 |
65 |
$1K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
17 |
12 |
$994.25 |
| 97803 |
|
13 |
12 |
$991.14 |
| 95806 |
|
12 |
12 |
$901.60 |
| 86431 |
|
123 |
123 |
$888.48 |
| 82962 |
|
206 |
203 |
$828.90 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
99 |
94 |
$823.56 |
| 82670 |
|
25 |
25 |
$771.12 |
| 87184 |
|
144 |
141 |
$755.67 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
25 |
25 |
$690.60 |
| 84436 |
|
190 |
189 |
$673.14 |
| 90480 |
|
26 |
26 |
$660.00 |
| 73600 |
|
14 |
12 |
$658.34 |
| 76857 |
|
12 |
12 |
$639.81 |
| 84153 |
|
29 |
29 |
$610.59 |
| 95251 |
|
12 |
12 |
$581.88 |
| 82043 |
|
87 |
86 |
$574.57 |
| 82465 |
|
102 |
102 |
$553.83 |
| 87625 |
|
26 |
26 |
$545.79 |
| 72220 |
|
12 |
12 |
$529.41 |
| 83001 |
|
25 |
25 |
$512.88 |
| 94667 |
|
41 |
40 |
$501.82 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
44 |
$452.58 |
| 91322 |
|
13 |
13 |
$437.76 |
| 87186 |
|
41 |
41 |
$424.56 |
| 84480 |
|
47 |
47 |
$411.87 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
13 |
13 |
$403.22 |
| 96161 |
|
179 |
158 |
$401.27 |
| 90656 |
|
787 |
786 |
$398.32 |
| 87077 |
|
41 |
41 |
$398.26 |
| 96380 |
|
26 |
26 |
$358.31 |
| 90474 |
|
55 |
55 |
$355.00 |
| 90619 |
|
415 |
414 |
$351.91 |
| 95024 |
|
14 |
14 |
$333.32 |
| 92558 |
|
26 |
26 |
$314.26 |
| 90651 |
|
189 |
189 |
$306.26 |
| 90670 |
|
1,977 |
1,975 |
$303.45 |
| 84550 |
|
51 |
51 |
$297.48 |
| 99406 |
|
13 |
13 |
$277.84 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
13 |
13 |
$258.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
146 |
140 |
$254.96 |
| 87088 |
|
26 |
26 |
$249.92 |
| 85610 |
|
49 |
48 |
$241.57 |
| J2785 |
Injection, regadenoson, 0.1 mg |
14 |
14 |
$222.86 |
| 82570 |
|
28 |
28 |
$180.80 |
| 82950 |
|
26 |
26 |
$161.18 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14 |
14 |
$136.22 |
| 90680 |
|
505 |
504 |
$89.25 |
| 98960 |
|
28 |
24 |
$80.20 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
119 |
111 |
$79.80 |
| 90698 |
|
306 |
306 |
$71.40 |
| 82272 |
|
12 |
12 |
$66.79 |
| J2704 |
Injection, propofol, 10 mg |
22 |
13 |
$54.41 |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
66 |
66 |
$53.32 |
| 85007 |
|
12 |
12 |
$48.07 |
| 87150 |
|
29 |
29 |
$40.35 |
| 94760 |
|
220 |
204 |
$26.85 |
| 3075F |
|
891 |
870 |
$20.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
100 |
95 |
$16.41 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
66 |
64 |
$6.45 |
| 91306 |
|
70 |
70 |
$0.01 |
| 3077F |
|
665 |
640 |
$0.00 |
| 1124F |
|
572 |
564 |
$0.00 |
| 90633 |
|
141 |
140 |
$0.00 |
| 90734 |
|
255 |
255 |
$0.00 |
| 91300 |
|
418 |
380 |
$0.00 |
| 90707 |
|
25 |
25 |
$0.00 |
| 96160 |
|
98 |
98 |
$0.00 |
| 90685 |
|
38 |
38 |
$0.00 |
| 90710 |
|
26 |
26 |
$0.00 |
| 90672 |
|
16 |
15 |
$0.00 |
| 90621 |
|
12 |
12 |
$0.00 |
| 91312 |
|
34 |
34 |
$0.00 |
| 3008F |
|
2,037 |
2,012 |
$0.00 |
| 99000 |
|
11,125 |
10,774 |
$0.00 |
| 3044F |
|
494 |
494 |
$0.00 |
| 90723 |
|
514 |
511 |
$0.00 |
| 90647 |
|
371 |
371 |
$0.00 |
| 97010 |
|
549 |
222 |
$0.00 |
| 36416 |
|
1,846 |
1,817 |
$0.00 |
| 3080F |
|
460 |
443 |
$0.00 |
| 90744 |
|
58 |
58 |
$0.00 |
| 91301 |
|
241 |
237 |
$0.00 |
| 99050 |
|
77 |
77 |
$0.00 |
| 90660 |
|
13 |
13 |
$0.00 |
| 99070 |
|
27 |
26 |
$0.00 |
| 90696 |
|
13 |
13 |
$0.00 |
| 91307 |
|
277 |
247 |
$0.00 |
| 90697 |
|
25 |
25 |
$0.00 |
| 91305 |
|
14 |
13 |
$0.00 |
| 90620 |
|
12 |
12 |
$0.00 |